More on TSHA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-44.4% Growth)
- Ratings (8.9 Score)

Upcoming Events

- Earnings (11/10/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Taysha Gene Therapies (NQ:TSHA)
Delayed: 5.70 +0.01 (0.18%)
Prev. Close $5.69  
Open$5.64 
52 Wk High$ 
52 Wk Low$ 
Day High$5.77 
Day Low$5.56 
P/E N/A  
EPS$ 
Volume1,763,156 

Friends, Peers and Foes (?): NGNE (more...)

Aug 14, 2026 04:50 PM Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 13, 2026 05:38 PM Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: MORGAN STANLEY
Aug 11, 2026 04:19 PM Taysha Gene Therapies (TSHA) Misses Q2 EPS by 1c
Aug 11, 2026 04:08 PM Form 10-Q Taysha Gene Therapies, For: Jun 30
Aug 11, 2026 04:06 PM Form 8-K Taysha Gene Therapies, For: Aug 11
Aug 11, 2026 04:00 PM Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 7, 2026 08:00 AM Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Aug 4, 2026 04:00 PM Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11
Aug 3, 2026 08:00 AM Taysha and Catalent sign commercial manufacturing deal for Rett therapy
Aug 3, 2026 08:00 AM Taysha Gene Therapies and Catalent Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome
View All Articles

Entities mentioned with TSHA

View All Entities